Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats

被引:62
作者
Arreola-Espino, Rosaura
Urquiza-Marin, Hector
Ambriz-Tututi, Monica
Araiza-Saldana, Claudia Ivonne
Caram-Salas, Nadia L.
Rocha-Gonzalez, Hector I.
Mixcoatl-Zecuatl, Teresa
Granados-Soto, Vinicio
机构
[1] Univ Michoacana, Inst Invest Quim Biol, Morelia, Michoacan, Mexico
[2] Ctr Invest & Estudios Avanzados, Dept Farmacobiol, Mexico City, DF, Mexico
关键词
melatonin; melatonin MT2 receptor; naltrexone; naltrindole; diabetes; tactile allodynia;
D O I
10.1016/j.ejphar.2007.09.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to assess the antinociceptive and antiallodynic effect of melatonin as well as its possible mechanism of action in diabetic rats. Streptozotocin (50 mg/kg) injection caused hyperglycemia within I week. Formalin-evoked flinching was increased in diabetic rats as compared to non-diabetic rats. Oral administration of melatonin (10-300 mg/kg) dose-dependently reduced flinching behavior in diabetic rats. In addition, K-185 (a melatonin MT2 receptor antagonist, 0.2-2 mg/kg, s.c.) completely blocked the melatonin-induced antinociception in diabetic rats, whereas that naltrexone (a non-selective opioid receptor antagonist, 1 mg/kg, s.c.) and naltrindole (a selective kappa opioid receptor antagonist, 0.5 mg/kg, s.c.), but not 5'-guanidinonaltrindole (a selective K opioid receptor antagonist, I mg/kg, s.c.), partially reduced the antinociceptive effect of melatonin. Given alone K-185, naltrexone, naltrindole or 5'-guanidinonaltrindole did not modify formalin-induced nociception in diabetic rats. Four to 8 weeks after diabetes induction, tactile allodynia was observed in the streptozotocin-injected rats. On this condition, oral administration of melatonin (75-300 mg/kg) dose-dependently reduced tactile allodynia in diabetic rats. Both antinociceptive and antiallodynic effects were not related to motor changes as melatonin did not modify number of falls in the rotarod test. Results indicate that melatonin is able to reduce formalin-induced nociception and tactile allodynia in streptozotocin-injected rats. In addition, data suggest that melatonin MT2 and delta opioid receptors may play an important role in these effects. (c) 2007 Elsevier B.V All rights reserved.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 54 条
  • [21] 5′-guanidinonaltrindole, a highly selective and potent κ-opioid receptor antagonist
    Jones, RM
    Portoghese, PS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (01) : 49 - 52
  • [22] Involvement of cholecystokinin in peripheral nociceptive sensitization during diabetes in rats as revealed by the formalin response
    Juarez-Rojop, Isela E.
    Granados-Soto, Vinicio
    Diaz-Zagoya, Juan C.
    Flores-Murrieta, Francisco J.
    Torres-Lopez, Jorge E.
    [J]. PAIN, 2006, 122 (1-2) : 118 - 125
  • [23] EFFECT OF DIABETES ON THE ANTINOCICEPTIVE EFFECT OF BETA-ENDORPHIN
    KAMEI, J
    KAWASHIMA, N
    HITOSUGI, H
    MISAWA, M
    NAGASE, H
    KASUYA, Y
    [J]. BRAIN RESEARCH, 1993, 619 (1-2) : 76 - 80
  • [24] Depression of glucose levels and partial restoration of pancreatic β-cell damage by melatonin in streptozotocin-induced diabetic rats
    Kanter, Mehmet
    Uysal, Hamdi
    Karaca, Turan
    Sagmanligil, Hulya Ozdemir
    [J]. ARCHIVES OF TOXICOLOGY, 2006, 80 (06) : 362 - 369
  • [25] Recent advances in molecular recognition and signal transduction of active peptides: Receptors for opioid peptides
    Kieffer, BL
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1995, 15 (06) : 615 - 635
  • [26] Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain
    Kim, HK
    Park, SK
    Zhou, JL
    Taglialatela, G
    Chung, K
    Coggeshall, RE
    Chung, JM
    [J]. PAIN, 2004, 111 (1-2) : 116 - 124
  • [27] Effects of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes
    Klepac, N
    Rudes, Z
    Klepac, R
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (01) : 32 - 35
  • [28] Melatonin enhances antinociceptive effects of δ-, but not μ-opioid agonist in mice
    Li, SR
    Wang, T
    Wang, R
    Dai, X
    Chen, Q
    Li, RD
    [J]. BRAIN RESEARCH, 2005, 1043 (1-2) : 132 - 138
  • [29] ATP-gated K+ channel openers enhance opioid antinociception:: indirect evidence for the release of endogenous opioid peptides
    Lohmann, AB
    Welch, SP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 385 (2-3) : 119 - 127
  • [30] Mechanisms involved in the antinociception caused by melatonin in mice
    Mantovani, Michela
    Kaster, Manuella P.
    Pertile, Roberto
    Calixto, Joao B.
    Rodrigues, Ana Lucia S.
    Santos, Adair R. S.
    [J]. JOURNAL OF PINEAL RESEARCH, 2006, 41 (04) : 382 - 389